PART I Company Overview We are a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer. Our first-in-class telomerase inhibitor, RYTELO (imetelstat), harnesses Nobel Prize winning science in a treatment that scientific evidence suggests reduces proliferation of malignant cells, allowing production of new healthy cells, which we believe drives differentiated clinical benefits, potentially altering the underlying course and modifying the disease o...
expected 2026-11-05
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-02 | 2025-12-31 | 0000886744-26-000008 | EDGAR | 95K words |
| 2025-02-27 | 2024-12-31 | 0000950170-25-027982 | EDGAR | — |
| 2024-02-28 | 2023-12-31 | 0000950170-24-022056 | EDGAR | — |
| 2023-03-16 | 2022-12-31 | 0000950170-23-008437 | EDGAR | — |
| 2022-03-10 | 2021-12-31 | 0001564590-22-009627 | EDGAR | — |
| 2021-03-11 | 2020-12-31 | 0001564590-21-012493 | EDGAR | — |
| 2020-03-12 | 2019-12-31 | 0001564590-20-010449 | EDGAR | — |
| 2019-03-07 | 2018-12-31 | 0001564590-19-006759 | EDGAR | — |
| 2018-03-16 | 2017-12-31 | 0001564590-18-006051 | EDGAR | — |
| 2017-03-01 | 2016-12-31 | 0001047469-17-001123 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-06-30 | 0000886744-26-000037 | EDGAR | — |
| 2025-11-07 | 2025-09-30 | 0000886744-25-000071 | EDGAR | 60K words |
| 2025-08-06 | 2025-06-30 | 0000886744-25-000052 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0000886744-25-000010 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0000950170-24-123282 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0000950170-24-093950 | EDGAR | — |
| 2024-05-02 | 2024-03-31 | 0000950170-24-052074 | EDGAR | — |
| 2023-11-02 | 2023-09-30 | 0000950170-23-057760 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0000950170-23-037931 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0000950170-23-020853 | EDGAR | — |
| 2022-11-07 | 2022-09-30 | 0000950170-22-022712 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0000950170-22-016839 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001193125-26-336508 | EDGAR | — |
| 2026-03-26 | 0001193125-26-125151 | EDGAR | 1K words |
| 2026-02-25 | 0001193125-26-068523 | EDGAR | — |
| 2026-01-12 | 0000886744-26-000003 | EDGAR | — |
| 2026-01-06 | 0001193125-26-003388 | EDGAR | — |
| 2025-12-16 | 0000886744-25-000074 | EDGAR | — |
| 2025-11-05 | 0000886744-25-000068 | EDGAR | — |
| 2025-10-14 | 0001628280-25-044862 | EDGAR | — |
| 2025-08-06 | 0000886744-25-000054 | EDGAR | — |
| 2025-08-06 | 0000886744-25-000048 | EDGAR | — |
351 total filings indexed. 319 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000886744 |
| Ticker | GERN |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.geron.com |
| Listed | 1996-07-31 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/GERN (~200 tokens, structured JSON with cryptographic provenance)